by Richard Daverman, PhD
March 7, 2013 -- According to reports, Sinopharm Holdings, one of China’s big-three drug distributors, will issue 4 billion RMB ($640 million) five-year corporate bonds on the Shanghai Stock Exchange. The purpose? The company declared only a not-particularly-specific need to “replenish working capital.” Can we expect the transaction to spark new M&A activity in China’s highly fragmented drug distribution system? More details....
Stock Symbol: (HK: 01099)
